More recently, gene mutations, such as TP53, DNA-methyltransferase-3a (DNMT3a) or ten-eleven translocation-2 (TET2) mutation, have been identified by the next-generation sequencing technique as very high-risk molecular markers for acute leukemia with low rate of remission and short survival [3–5]. The gene discussed is TET2; the disease is acute leukemia.